Top Markets
Coin of the day
Diagnocure, Inc. Diagnocure, Inc.

Diagnocure, Inc.

DGCRF
Rang in aandelen #41419
Diagnocure, Inc. is a Canadian life sciences company dedicated to developing... Diagnocure, Inc. is a Canadian life sciences company dedicated to developing and commercializing innovative products for cancer diagnosis. Its core business revolves around advanced molecular diagnostic tests designed for the identification and management of cancerous conditions. The company's portfolio includes the PCA3 test for prostate cancer diagnosis, as well as the Guanylyl Cyclase C (GCC) marker and the Previstage GCC colorectal cancer staging test, both vital for patients with colorectal cancer. They also offer PCP, a multi-marker diagnostic for prostate cancer. In addition to these tests, Diagnocure provides specialized services such as gene expression and copy number variation analysis, mutation detection, SNP genotyping, and comprehensive platform and laboratory environmental support. Established in 1994 as 9342-8530 Québec Inc. and previously known as DiagnoCure Inc., the company is headquartered in Quebec, Canada.
Aandeelprijs
$0.0001
Laatst gesynchroniseerd: 2025-06-11
Marktkapitalisatie
$21.52K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
CA
Handel Diagnocure, Inc. (DGCRF)

Categorie

Prijs DGCRF met de marktkapitalisatie van B
Diagnocure, Inc. Diagnocure, Inc.
DGCRF
$0.0001
Marktkapitalisatie van Diagnocure, Inc.(DGCRF)
Marktkapitalisatie: $21.52K
Vanaf August 2026 heeft Diagnocure, Inc. een marktkapitalisatie van $21.52K. Dit maakt Diagnocure, Inc. volgens onze gegevens het 41419th meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van Diagnocure, Inc. van 2012 tot 2026
DGCRF vergeleken met de top 5 populairste stocks
Prijs voor DGCRF Aandeel B Marktkapitalisatie van B uitslagen
Diagnocure, Inc. Diagnocure, Inc.
$25,015.61 $21.52K
$5.383T +25,015,610,773.61%
Diagnocure, Inc. Diagnocure, Inc.
$20,554.79 $21.52K
$4.423T +20,554,791,738.93%
Diagnocure, Inc. Diagnocure, Inc.
$19,332.57 $21.52K
$4.160T +19,332,571,457.07%
Diagnocure, Inc. Diagnocure, Inc.
$17,022.87 $21.52K
$3.663T +17,022,866,242.94%
Diagnocure, Inc. Diagnocure, Inc.
$13,435.08 $21.52K
$2.891T +13,435,077,945.54%